Axio BioPharma

Axio BioPharma is at the forefront of biotechnology research, dedicated to transforming biopharmaceutical manufacturing as a leading Contract Development and Manufacturing Organization (CDMO). Located at 504 S. Rosa Road, Suite 200, Madison, Wisconsin 53719, US, Axio BioPharma accelerates the development of mammalian-expressed recombinant proteins, with a strong focus on monoclonal antibodies (mAbs). Their innovative approach significantly reduces the timeline from initial lab research to clinical manufacturing, facilitating the faster delivery of critical therapies to patients. Additionally, Axio BioPharma has a location at The Black Church, St. Mary's Place, Dublin, IE.

Driven by a commitment to accelerate innovation, Axio BioPharma leverages advanced technologies and AI-driven strategies to enhance bioprocessing and biomanufacturing. The company specializes in a comprehensive suite of services including cell line development, biologics, protein purification, process development, and CMC development. Axio BioPharma's dedication to high-throughput screening and mammalian cell culture positions it as a key partner in advancing therapeutic antibodies and biologics scale-up.

With a focus on upstream and downstream processing, Axio BioPharma ensures the highest standards in contract manufacturing. Axio BioPharma is committed to enabling quicker access to life-saving therapies. We invite the manager of Axio BioPharma to create a customized and exclusive company showcase and product listing on our platform to further highlight their exceptional capabilities and accelerate commercial development.